Rejection of drug a blow for Australians living with Alzheimer’s disease
LISTEN TO PODCAST NOW
Podcast: Play in new window | Download (Duration: 9:45 — 13.4MB)
Subscribe or Follow Us: Apple Podcasts | Spotify | RSS
A new treatment for people living with the early stages of Alzheimer’s disease or mild cognitive impairment has been rejected by the Therapeutic Goods Administration (TGA).
With Dementia becoming the leading cause of death in Australia, it’s disappointing news for those impacted by Alzheimers.
Guest: Dr Kaele Stokes is Dementia Australia’s Executive Director – Services, Advocacy & Research.
Presenter: Warren Andrew.
Podcast: Play in new window | Download (Duration: 9:45 — 13.4MB)
Subscribe or Follow Us: Apple Podcasts | Spotify | RSS
RECENT PODCAST
Associate Professor Lauren Rosewarne: Why We’re Pushing Back Against Perfect Faces
After years of smooth, interchangeable faces on screens, something is shifting. Associate Professor Lauren Rosewarne unpacks why expressive, readable faces ...
LISTEN TO PODCAST NOW
Podcast: Play in new window | Download (Duration: 15:34 — 21.4MB)
Subscribe or Follow Us: Apple Podcasts | Spotify | RSS
Dr Dee Tomic: Work Participation, Inequality and Feeling Safe at Work
Work participation isn’t just about skills or effort; it’s shaped by whether workplaces feel safe, welcoming and secure. Dr Dee ...
LISTEN TO PODCAST NOW
Podcast: Play in new window | Download (Duration: 12:33 — 17.2MB)
Subscribe or Follow Us: Apple Podcasts | Spotify | RSS
Nicole Rich: What Renters and Donors Need to Know After a Disaster
After bushfires and other disasters, everyday rules around renting, repairs and donations can quickly become unclear. Nicole Rich outlines renter ...
LISTEN TO PODCAST NOW
Podcast: Play in new window | Download (Duration: 13:49 — 19.0MB)
Subscribe or Follow Us: Apple Podcasts | Spotify | RSS